CP smart home AI health services will be launched this year. Guangxi Liuyao Group: The new online settlement policy is conducive to improving the current high accounts receivable situation. | Direct hit earnings conference
At the earnings conference, Chairman Zhu Chaoyang of Guangxi Liuyao Group introduced the progress of the company's AI scenario application business. For the high accounts receivable, the company's CFO Zeng Xiangxing stated that the company has adjusted its operational strategy and strengthened the collection efforts. Guangxi Liuyao Group also responded to the slight decline in growth of the pharmaceutical wholesale sector and issues related to the expansion of pharmaceutical new retail business.
A subsidiary has been "blacklisted" by Shenzhen for one year. Jointown Pharmaceutical Group claims to be "in the process of defending". The industry believes that the intensity of procurement supervision is continuously increasing.
Recently, Jointown Pharmaceutical Group's subsidiary, Jointown Medical Device, was fined and banned from participating in Shenzhen procurement for one year due to providing false information in a tender at a hospital in Shenzhen. Jointown Pharmaceutical Group responded to a reporter from Caijing.com.cn, stating that this incident is a pending matter, and they have organized appeal materials and are currently undergoing administrative reconsideration. This year, several listed companies have been fined for violations in the bidding and procurement process, leading industry insiders to suggest that companies should pay more attention to compliance with details during the bidding process.
Suddenly surged by 110%! Monkeypox epidemic is spreading, and concept stocks are soaring across the board.
As a new round of monkeypox outbreaks catches market attention, pharmaceutical companies and related stocks involved in the production and development of monkeypox vaccines have seen a significant rise in their stock prices. The most ferocious performer is the monkeypox concept stock Geovax Labs in the US market, whose stock price surged by 110% last Friday; Emergent Biosolutions rose by over 24%.
LBX Pharmacy Chain Joint Stock announced that its chairman has been detained, but the company claims that the incident has nothing to do with its operation, and everything is running as usual. | Quick announcement reading.
1. Lbx Pharmacy Chain Joint Stock announced that company's actual controller and chairman Xie Zilong has been detained and investigated. 2. The matters involved are not related to the company. 3. The operation of the listed company is normal.
Hu Xinwei, Qiu Dongrong, and Feng Mingyuan's adjustment operations are emerging. Foreign capital seems to be more interested in small cap stocks.
① Hu Xinwei has been reducing shareholding of Chacha Food for 3 consecutive quarters, Qiu Dongrong has been reducing shareholding of Shanying International Holdings for 2 consecutive quarters; ② Yixintang and Yunnan Jianzhijia are the top two pharmaceutical retail chain stocks in Yunnan. Wanminyuan reduced shareholding of the former in June and increased shareholding of the latter; ③ Zheng Zehong and Li Rui both increased shareholding of Shanghai Putailai New Energy Technology; ④ Common foreign institutions such as Goldman Sachs and Morgan Stanley adjusted their holdings of small cap stocks.
LBX Pharmacy Chain Joint Stock Chairman: Outpatient pooling policy is bullish for compliant leading companies, cautious about mergers and acquisitions this year | Direct report of the shareholder meeting
As the standard for including pharmacies in outpatient planning is being raised and regulation is becoming stricter, this trend is beneficial for compliant leading enterprises. This year, the company will be more cautious in its acquisitions, but will still rapidly expand through self-built and franchised stores.